Anshan Hifichem Co Ltd (300758) - Net Assets
Based on the latest financial reports, Anshan Hifichem Co Ltd (300758) has net assets worth CN¥1.96 Billion CNY (≈ $286.75 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.89 Billion ≈ $569.96 Million USD) and total liabilities (CN¥1.94 Billion ≈ $283.20 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Anshan Hifichem Co Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.96 Billion |
| % of Total Assets | 50.31% |
| Annual Growth Rate | 20.35% |
| 5-Year Change | 40.39% |
| 10-Year Change | 418.57% |
| Growth Volatility | 33.91 |
Anshan Hifichem Co Ltd - Net Assets Trend (2014–2024)
This chart illustrates how Anshan Hifichem Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Anshan Hifichem Co Ltd (300758) total assets for the complete picture of this company's asset base.
Annual Net Assets for Anshan Hifichem Co Ltd (2014–2024)
The table below shows the annual net assets of Anshan Hifichem Co Ltd from 2014 to 2024. For live valuation and market cap data, see how much is Anshan Hifichem Co Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.88 Billion ≈ $275.54 Million |
+6.97% |
| 2023-12-31 | CN¥1.76 Billion ≈ $257.60 Million |
+3.63% |
| 2022-12-31 | CN¥1.70 Billion ≈ $248.57 Million |
-6.33% |
| 2021-12-31 | CN¥1.81 Billion ≈ $265.38 Million |
+35.22% |
| 2020-12-31 | CN¥1.34 Billion ≈ $196.26 Million |
+19.00% |
| 2019-12-31 | CN¥1.13 Billion ≈ $164.93 Million |
+118.82% |
| 2018-12-31 | CN¥515.08 Million ≈ $75.37 Million |
+25.72% |
| 2017-12-31 | CN¥409.70 Million ≈ $59.95 Million |
+14.19% |
| 2016-12-31 | CN¥358.78 Million ≈ $52.50 Million |
-1.19% |
| 2015-12-31 | CN¥363.11 Million ≈ $53.13 Million |
+22.92% |
| 2014-12-31 | CN¥295.41 Million ≈ $43.23 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Anshan Hifichem Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 337.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥494.41 Million | 28.85% |
| Common Stock | CN¥406.04 Million | 23.70% |
| Other Components | CN¥813.15 Million | 47.45% |
| Total Equity | CN¥1.71 Billion | 100.00% |
Anshan Hifichem Co Ltd Competitors by Market Cap
The table below lists competitors of Anshan Hifichem Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
|
$778.09 Million |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
$778.12 Million |
|
Beijing North Star Co Ltd Class A
SHG:601588
|
$778.48 Million |
|
Guangdong Silvere Sci and Tech
SHE:300221
|
$778.52 Million |
|
Ubisoft Entertainment
PA:UBI
|
$777.86 Million |
|
Baticim Bati Anadolu Cimento Sanayi AS
IS:BTCIM
|
$777.36 Million |
|
Sudarshan Chemical Industries Limited
NSE:SUDARSCHEM
|
$777.34 Million |
|
SERVICE STREAM LTD
F:UFY
|
$777.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Anshan Hifichem Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,602,350,191 to 1,713,599,210, a change of 111,249,019 (6.9%).
- Net income of 124,931,115 contributed positively to equity growth.
- Dividend payments of 54,439,481 reduced retained earnings.
- Share repurchases of 13,560,878 reduced equity.
- Other comprehensive income decreased equity by 35,324,909.
- Other factors increased equity by 89,643,172.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥124.93 Million | +7.29% |
| Dividends Paid | CN¥54.44 Million | -3.18% |
| Share Repurchases | CN¥13.56 Million | -0.79% |
| Other Comprehensive Income | CN¥-35.32 Million | -2.06% |
| Other Changes | CN¥89.64 Million | +5.23% |
| Total Change | CN¥- | 6.94% |
Book Value vs Market Value Analysis
This analysis compares Anshan Hifichem Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.13x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 11.40x to 3.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CN¥1.17 | CN¥13.32 | x |
| 2015-12-31 | CN¥2.55 | CN¥13.32 | x |
| 2016-12-31 | CN¥2.50 | CN¥13.32 | x |
| 2017-12-31 | CN¥1.67 | CN¥13.32 | x |
| 2018-12-31 | CN¥2.11 | CN¥13.32 | x |
| 2019-12-31 | CN¥3.62 | CN¥13.32 | x |
| 2020-12-31 | CN¥3.78 | CN¥13.32 | x |
| 2021-12-31 | CN¥4.39 | CN¥13.32 | x |
| 2022-12-31 | CN¥5.68 | CN¥13.32 | x |
| 2023-12-31 | CN¥4.37 | CN¥13.32 | x |
| 2024-12-31 | CN¥4.25 | CN¥13.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Anshan Hifichem Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.29%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.97%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 2.17x
- Recent ROE (7.29%) is below the historical average (11.44%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 6.15% | 5.63% | 0.55x | 1.97x | CN¥-11.37 Million |
| 2015 | 10.69% | 10.51% | 0.65x | 1.57x | CN¥2.52 Million |
| 2016 | 21.09% | 17.12% | 0.79x | 1.56x | CN¥39.79 Million |
| 2017 | 25.23% | 18.70% | 0.94x | 1.44x | CN¥62.41 Million |
| 2018 | 20.46% | 17.25% | 0.82x | 1.44x | CN¥53.87 Million |
| 2019 | 9.59% | 15.56% | 0.48x | 1.28x | CN¥-4.61 Million |
| 2020 | 14.29% | 17.40% | 0.52x | 1.57x | CN¥52.67 Million |
| 2021 | 10.48% | 13.36% | 0.51x | 1.53x | CN¥8.25 Million |
| 2022 | -0.18% | -0.23% | 0.40x | 1.90x | CN¥-161.54 Million |
| 2023 | 0.69% | 0.90% | 0.35x | 2.14x | CN¥-149.23 Million |
| 2024 | 7.29% | 7.97% | 0.42x | 2.17x | CN¥-46.43 Million |
Industry Comparison
This section compares Anshan Hifichem Co Ltd's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $4,145,101,575
- Average return on equity (ROE) among peers: 2.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Anshan Hifichem Co Ltd (300758) | CN¥1.96 Billion | 6.15% | 0.99x | $777.93 Million |
| Chongqing Sanxia Paints Co Ltd (000565) | $420.42 Million | 6.58% | 1.35x | $499.34 Million |
| Hengyi Petrochemical Co Ltd (000703) | $90.42 Million | 27.06% | 0.87x | $9.30 Billion |
| Guangdong Xinhui Meida Nylon Co Ltd (000782) | $1.09 Billion | 0.96% | 1.41x | $741.46 Million |
| Luxi Chemical Group Co Ltd (000830) | $17.46 Billion | 18.08% | 0.97x | $4.75 Billion |
| China Minmetals Rare Earth Co Ltd (000831) | $2.74 Billion | 9.31% | 0.09x | $8.45 Billion |
| Anhui Guofeng Plastic Industry Co Ltd (000859) | $1.39 Billion | 0.45% | 0.38x | $1.19 Billion |
| Cofco Biochemical Anhui Co Ltd (000930) | $1.57 Billion | -90.11% | 2.59x | $1.65 Billion |
| Shandong Link Science and Technology Co Ltd (001207) | $198.24 Million | 18.03% | 1.03x | $582.05 Million |
| Zhejiang Transfar Co Ltd (002010) | $16.39 Billion | 9.78% | 0.86x | $2.36 Billion |
| Poly Union Chemical Holding Group Co Ltd (002037) | $107.09 Million | 21.41% | 1.19x | $605.40 Million |
About Anshan Hifichem Co Ltd
Anshan Hifichem Co., Ltd. engages in the research, development, manufacture, and sale of high-performance organic pigments, dyestuff, and intermediates in China. It offers lead chrome yellow and molybate orange pigments, solvent dyestuff, and inks for use in various industries, such as Vehicle paint and refinish paint, industrial coating, powder coating, 3c coatings, construction, architecture pa… Read more